---
figid: PMC7048131__12964_2020_527_Fig5_HTML
figlink: pmc/articles/PMC7048131/figure/Fig5/
number: Fig. 5
caption: Advances of the STAT3 signaling pathways involving breast cancer chemoresistance.
  Classical IL-6/JAK/STAT3 pathways can induce chemoresistance in breast cancer, while
  miR-4532 may attenuate this effect by inhibiting HIC-1 and IL-6/STAT3 pathways.
  Leukemia inhibitory factor (LIF) binding to its receptor LIFR can increase the activation
  of STAT3. STAT3 and pSTAT3 levels are regulated by GRP78. Then, phosphorylated STAT3
  activates cellular molecules including FAO, CPT1B and MAPK/AKT to induce the chemoresistance
  of breast cancer. Oct-4 and c-Myc form a signaling loop to promote STAT3/NF-κB activation
  and chemoresistance in breast cancer. Additionally, miR-124 can inhibit HIF-1 and
  promote breast cancer chemoresistance
pmcid: PMC7048131
papertitle: Role of STAT3 signaling pathway in breast cancer.
reftext: Jia-hui Ma, et al. Cell Commun Signal. 2020;18:33.
pmc_ranked_result_index: '7309'
pathway_score: 0.9648319
filename: 12964_2020_527_Fig5_HTML.jpg
figtitle: Advances of the STAT3 signaling pathways involving breast cancer chemoresistance
year: '2020'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7048131__12964_2020_527_Fig5_HTML.html
  '@type': Dataset
  description: Advances of the STAT3 signaling pathways involving breast cancer chemoresistance.
    Classical IL-6/JAK/STAT3 pathways can induce chemoresistance in breast cancer,
    while miR-4532 may attenuate this effect by inhibiting HIC-1 and IL-6/STAT3 pathways.
    Leukemia inhibitory factor (LIF) binding to its receptor LIFR can increase the
    activation of STAT3. STAT3 and pSTAT3 levels are regulated by GRP78. Then, phosphorylated
    STAT3 activates cellular molecules including FAO, CPT1B and MAPK/AKT to induce
    the chemoresistance of breast cancer. Oct-4 and c-Myc form a signaling loop to
    promote STAT3/NF-κB activation and chemoresistance in breast cancer. Additionally,
    miR-124 can inhibit HIF-1 and promote breast cancer chemoresistance
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - NDUFC2
  - HIC1
  - IL6
  - IL6R
  - LIF
  - LIFR
  - JAK1
  - JAK2
  - JAK3
  - TYK2
  - NFKB1
  - NFKB2
  - REL
  - RELA
  - RELB
  - HSPA5
  - STAT3
  - SETD2
  - MAPK14
  - MAPK3
  - MAPK8
  - MAPK11
  - MAPK13
  - MAPK12
  - MAPK1
  - MAPK9
  - MAPK10
  - MAK
  - CPT1B
  - AKT2
  - AKT3
  - AKT1
  - MYC
genes:
- word: HIC-1
  symbol: HLC-1
  source: hgnc_alias_symbol
  hgnc_symbol: NDUFC2
  entrez: '4718'
- word: HIC-1
  symbol: HIC1
  source: hgnc_symbol
  hgnc_symbol: HIC1
  entrez: '3090'
- word: IL-6
  symbol: IL-6
  source: hgnc_alias_symbol
  hgnc_symbol: IL6
  entrez: '3569'
- word: IL-6/IL-6R/gp130
  symbol: IL-6
  source: hgnc_alias_symbol
  hgnc_symbol: IL6
  entrez: '3569'
- word: IL-6/IL-6R/gp130
  symbol: IL6R
  source: hgnc_symbol
  hgnc_symbol: IL6R
  entrez: '3570'
- word: LIF
  symbol: LIF
  source: hgnc_symbol
  hgnc_symbol: LIF
  entrez: '3976'
- word: LIFR/gp130
  symbol: LIFR
  source: hgnc_symbol
  hgnc_symbol: LIFR
  entrez: '3977'
- word: JAK
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: JAK1
  entrez: '3716'
- word: JAK
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: JAK2
  entrez: '3717'
- word: JAK
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: JAK3
  entrez: '3718'
- word: JAK
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: TYK2
  entrez: '7297'
- word: IL-6R
  symbol: IL6R
  source: hgnc_symbol
  hgnc_symbol: IL6R
  entrez: '3570'
- word: NF-KB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: NFKB1
  entrez: '4790'
- word: NF-KB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: NFKB2
  entrez: '4791'
- word: NF-KB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: REL
  entrez: '5966'
- word: NF-KB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: RELA
  entrez: '5970'
- word: NF-KB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: RELB
  entrez: '5971'
- word: GRP78
  symbol: GRP78
  source: hgnc_prev_symbol
  hgnc_symbol: HSPA5
  entrez: '3309'
- word: STAT3
  symbol: STAT3
  source: hgnc_symbol
  hgnc_symbol: STAT3
  entrez: '6774'
- word: STAT3
  symbol: STAT3
  source: hgnc_symbol
  hgnc_symbol: STAT3
  entrez: '6774'
- word: HIF-1
  symbol: HIF-1
  source: hgnc_alias_symbol
  hgnc_symbol: SETD2
  entrez: '29072'
- word: МАРК
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK14
  entrez: '1432'
- word: МАРК
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: МАРК
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK8
  entrez: '5599'
- word: МАРК
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK11
  entrez: '5600'
- word: МАРК
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK13
  entrez: '5603'
- word: МАРК
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK12
  entrez: '6300'
- word: МАРК
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: МАРК
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK9
  entrez: '5601'
- word: МАРК
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK10
  entrez: '5602'
- word: МАРК
  symbol: MAK
  source: hgnc_symbol
  hgnc_symbol: MAK
  entrez: '4117'
- word: CPT1B
  symbol: CPT1B
  source: hgnc_symbol
  hgnc_symbol: CPT1B
  entrez: '1375'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: с-Мус
  symbol: c-Myc
  source: hgnc_alias_symbol
  hgnc_symbol: MYC
  entrez: '4609'
chemicals: []
diseases: []
---
